Seoul National University Hospital announced on the 10th that Professor Han Won-sik of the Department of Breast and Endocrine Surgery was inaugurated as the 11th President of the Korean Breast Cancer Society on the 27th of last month. His term is two years starting this month.


Professor Han Won-sik, Department of Breast and Endocrine Surgery, Seoul National University Hospital. [Photo by Seoul National University Hospital]

Professor Han Won-sik, Department of Breast and Endocrine Surgery, Seoul National University Hospital. [Photo by Seoul National University Hospital]

View original image

The Korean Breast Cancer Society was established in 1999 to promote academic activities related to breast cancer. It operates in a multidisciplinary manner, involving not only surgery but also oncology, radiation oncology, radiology, pathology, plastic surgery, and nursing departments. The society holds the 'Global Breast Cancer Conference (GBCC)' annually, attended by more than 2,500 breast cancer experts from over 30 countries.


As the 11th President of the Korean Breast Cancer Society, Professor Han plans to lead the society for the next two years, spearheading research, presentations, and knowledge exchange on breast cancer. At the same time, as the Chair of the GBCC Organizing Committee, he aims to activate various breast cancer-related research projects and networking.


Professor Han stated, "In the past, breast cancer research was actively conducted in the United States and Europe, leaving Korea on the periphery of breast cancer research. However, through the Korean Breast Cancer Society's efforts over the past 25 years, Korea has come to stand shoulder to shoulder with advanced countries in the fields of breast cancer diagnosis, treatment, basic research, and clinical trials." He added, "Going forward, we will strive to become a society that values women's health as the highest priority, leading Asia and influencing the world."



Meanwhile, Professor Han has served as a director of the Korean Breast Cancer Society, a director of the Korean Cancer Society, vice president of the Korean Society of Genomics, and president of the Breast Cancer Translational Research Group.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing